Back
Cullinan Therapeutics Stock Price Chart
Sponsored
CGEM
Sponsored
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Buy
59
CGEM
Cullinan Therapeutics
Last Price:
27.05
Seasonality Move:
13.37%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).- The current trend is moderately bullish and CGEM is experiencing selling pressure, which indicates risk of future bearish movement.
Cullinan Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.51 | Sell |
20-day SMA: | 23.86 | Buy |
50-day SMA: | 19.63 | Buy |
200-day SMA: | 13.19 | Buy |
8-day EMA: | 26.67 | Sell |
20-day EMA: | 24.53 | Buy |
50-day EMA: | 20.94 | Buy |
200-day EMA: | 15.13 | Buy |
Cullinan Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.5 | Buy |
Relative Strength Index (14 RSI): | 63.79 | Buy |
Chaikin Money Flow: | -382547 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.35 - 27.63) | Buy |
Bollinger Bands (100): | (11.95 - 21.89) | Buy |
Cullinan Therapeutics Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cullinan Therapeutics Stock
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 26.38 while CGEM 8-day simple moving average is 27.51, which is a Sell signal.
- The stock price of CGEM is 26.38 while Cullinan Therapeutics 20-day SMA is 23.86, which makes it a Buy.
- Cullinan Therapeutics 50-day simple moving average is 19.63 while CGEM share price is 26.38, making it a Buy technically.
- CGEM stock price is 26.38 and Cullinan Therapeutics 200-day simple moving average is 13.19, creating a Buy signal.
CGEM Technical Analysis vs Fundamental Analysis
Buy
59
Cullinan Therapeutics (CGEM)
is a Buy
Is Cullinan Therapeutics a Buy or a Sell?
-
Cullinan Therapeutics stock is rated a Buy
The current Cullinan Therapeutics [CGEM] share price is $26.38. The Score for CGEM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Cullinan Therapeutics Stock Info
Market Cap:
1.14B
Price in USD:
26.38
Share Volume:
641.17K
Cullinan Therapeutics 52-Week Range
52-Week High:
30.19
52-Week Low:
7.64
Buy
59
Cullinan Therapeutics (CGEM)
is a Buy
Cullinan Therapeutics Share Price Forecast
-
What is the Cullinan Therapeutics stock price today?
The Cullinan Therapeutics stock price is 26.38 USD today. -
Will CGEM stock go up or go down?
Cullinan Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cullinan Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cullinan Therapeutics is not overvalued.
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 26.38 while CGEM 8-day exponential moving average is 26.67, which is a Sell signal.
- The stock price of CGEM is 26.38 while Cullinan Therapeutics 20-day EMA is 24.53, which makes it a Buy.
- Cullinan Therapeutics 50-day exponential moving average is 20.94 while CGEM share price is 26.38, making it a Buy technically.
- CGEM stock price is 26.38 and Cullinan Therapeutics 200-day simple moving average is 15.13, creating a Buy signal.
Fundamental Analysis of Cullinan Therapeutics
Is Cullinan Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.57 per share, and an increase next year of $0.23 per share.
Technical Analysis of Cullinan Therapeutics
Should I short Cullinan Therapeutics stock?
- CGEM Moving Average Covergence Divergence (MACD) indicator is 2.5, suggesting Cullinan Therapeutics is a Buy
- Cullinan Therapeutics Relative Strength Index (RSI) is 63.79, which suggest Cullinan Therapeutics is overbought
- The Bollinger Bands (25) for Cullinan Therapeutics is (17.35 - 27.63), which suggest Cullinan Therapeutics is a Buy
- The Bollinger Bands (100) for Cullinan Therapeutics is (11.95 - 21.89), which suggest Cullinan Therapeutics is a Buy
* Cullinan Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.